Market News

Costco Wholesale (COST) Valuation Rose While Beach Investment Counsel Has Lowered by $413,600 Its Stake; As Abbvie (ABBV) Share Value Declined, Shareholder Hsbc Holdings Plc Cut Its Stake

AbbVie Inc. (NYSE:ABBV) Logo

Hsbc Holdings Plc decreased its stake in Abbvie Inc (ABBV) by 22.17% based on its latest 2018Q1 regulatory filing with the SEC. Hsbc Holdings Plc sold 1.03M shares as the company’s stock declined 16.83% with the market. The institutional investor held 3.62M shares of the major pharmaceuticals company at the end of 2018Q1, valued at $342.43 million, down from 4.65 million at the end of the previous reported quarter. Hsbc Holdings Plc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $150.76B market cap company. The stock increased 0.83% or $0.82 during the last trading session, reaching $99.57. About 20.81M shares traded or 126.42% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since June 17, 2017 and is uptrending. It has outperformed by 39.84% the S&P500. Some Historical ABBV News: 09/03/2018 – $CHRS $ABBV Both Coherus ‘182 and ‘522 IPR patent trials denied on Enbrel patent claims; 02/04/2018 – AbbVie’s Mavyret Falls For 2nd Wk, Zepatier Declines: Hep-C; 05/04/2018 – SAMSUNG BIOEPIS SETTLES PATENT DISPUTES WITH ABBVIE, CLEARING; 26/04/2018 – ABBVIE INC ABBV.N SEES FY 2018 GAAP SHR $6.82 TO $6.92; 18/05/2018 – FDA – MERCK, GENENTECH HAVE STOPPED ENROLLING PATIENTS WHOSE TUMORS HAVE PD-L1 LOW STATUS TO KEYTRUDA/TECENTRIQ MONOTHERAPY ARMS PER DMCS’ RECOMMENDATIONS; 22/03/2018 – ABBVIE INC – WILL NOT SEEK ACCELERATED APPROVAL FOR ROVA-T IN THIRD-LINE RELAPSED/REFRACTORY SMALL CELL LUNG CANCER; 09/04/2018 – Merck: Keytruda Significantly Improves Overall Survival in Study; 05/04/2018 – Biogen, Samsung Bioepis to Make Royalty Payments to AbbVie; 01/05/2018 – AbbVie: Tender Offer and Withdrawal Rights Will Expire at Midnight ET May 29, 2018; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2

Beach Investment Counsel Inc decreased its stake in Costco Wholesale (COST) by 9.86% based on its latest 2018Q1 regulatory filing with the SEC. Beach Investment Counsel Inc sold 2,200 shares as the company’s stock rose 2.88% while stock markets declined. The hedge fund held 20,117 shares of the department and specialty retail stores company at the end of 2018Q1, valued at $3.79 million, down from 22,317 at the end of the previous reported quarter. Beach Investment Counsel Inc who had been investing in Costco Wholesale for a number of months, seems to be less bullish one the $90.92B market cap company. The stock increased 1.07% or $2.2 during the last trading session, reaching $207.32. About 2.93 million shares traded or 38.78% up from the average. Costco Wholesale Corporation (NASDAQ:COST) has risen 13.52% since June 17, 2017 and is uptrending. It has outperformed by 0.95% the S&P500. Some Historical COST News: 19/04/2018 – National Business Group on Health Recognizes Costco Wholesale Corporation with 2018 Helen Darling Award for Excellence in Healt; 07/03/2018 – COSTCO WHOLESALE CORP – NET SALES FOR QUARTER INCREASED 10.8 PERCENT, TO $32.28 BLN FROM $29.13 BLN LAST YEAR; 07/03/2018 – COSTCO WHOLESALE CORP COST.O – SECOND QUARTER TRAFFIC OR SHOPPING FREQUENCY WAS UP 3.7% WORLDWIDE AND 3.4% IN THE U.S. – CONF CALL; 09/05/2018 – COSTCO WHOLESALE CORP COST.O SAYS TOTAL COMPANY COMPARABLE SALES 10.9% IN APRIL; 09/05/2018 – Costco Wholesale Corporation Reports April Sales Results; 11/04/2018 – Costco Wholesale Corporation Reports March Sales Results; 07/03/2018 – COSTCO WHOLESALE CORP – QTRLY COMPARABLE SALES UP 5.4 PCT, W/O GAS INFLATION & FX; 14/03/2018 – EnWave Receives Repeat Costco Orders from Midwest Division and Announces Distribution of Moon Cheese into Second Costco Division; 06/04/2018 – China trade dispute could slam U.S. retailers; 06/03/2018 Costco Wholesale Corp expected to post earnings of $1.46 a share – summary

Beach Investment Counsel Inc, which manages about $1.43 billion and $959.99M US Long portfolio, upped its stake in Morgan Stanley (NYSE:MS) by 70,430 shares to 246,060 shares, valued at $13.28M in 2018Q1, according to the filing. It also increased its holding in Energy Transfer Equity Lp (NYSE:ETE) by 327,488 shares in the quarter, for a total of 1.15 million shares, and has risen its stake in Williams Companies Inc (NYSE:WMB).

Analysts await Costco Wholesale Corporation (NASDAQ:COST) to report earnings on October, 4. They expect $2.28 EPS, up 9.62% or $0.20 from last year’s $2.08 per share. COST’s profit will be $999.88 million for 22.73 P/E if the $2.28 EPS becomes a reality. After $1.70 actual EPS reported by Costco Wholesale Corporation for the previous quarter, Wall Street now forecasts 34.12% EPS growth.

Investors sentiment decreased to 0.92 in 2018 Q1. Its down 0.06, from 0.98 in 2017Q4. It is negative, as 62 investors sold COST shares while 440 reduced holdings. 92 funds opened positions while 371 raised stakes. 305.24 million shares or 0.97% less from 308.22 million shares in 2017Q4 were reported. Bessemer reported 0.31% in Costco Wholesale Corporation (NASDAQ:COST). Seizert Prtnrs Limited Liability Company has invested 0.01% in Costco Wholesale Corporation (NASDAQ:COST). Profit Inv Ltd Liability holds 5,960 shares or 0.95% of its portfolio. South State Corporation invested in 1.07% or 49,362 shares. Royal State Bank Of Scotland Group Inc Public Ltd Company reported 0.07% stake. Northern Trust has 0.3% invested in Costco Wholesale Corporation (NASDAQ:COST). Philadelphia Tru holds 0.05% of its portfolio in Costco Wholesale Corporation (NASDAQ:COST) for 2,995 shares. Horan Management, Maryland-based fund reported 4,093 shares. Confluence Wealth Management Ltd reported 6,151 shares stake. Credit Suisse Ag has invested 0.09% of its portfolio in Costco Wholesale Corporation (NASDAQ:COST). 87,196 were reported by Hartford Inv Co. Forward Mgmt Ltd Limited Liability Company reported 3,675 shares. Aristotle Capital Mngmt Ltd Llc invested in 1,100 shares or 0% of the stock. 7,185 are held by Northern Management Ltd Liability Corporation. 232,312 were accumulated by Boston Advsrs Limited Liability.

Since December 18, 2017, it had 0 buys, and 16 insider sales for $19.94 million activity. Shares for $958,087 were sold by GALANTI RICHARD A. $937,421 worth of Costco Wholesale Corporation (NASDAQ:COST) was sold by Murphy James P. on Friday, January 5. 5,200 shares were sold by Vachris Roland Michael, worth $977,510 on Monday, January 8. Shares for $1.43 million were sold by Hines Daniel M.. On Thursday, April 19 the insider Miller Russell D sold $2.41 million. $3.86 million worth of Costco Wholesale Corporation (NASDAQ:COST) was sold by LIBENSON RICHARD M on Monday, December 18.

More notable recent Costco Wholesale Corporation (NASDAQ:COST) news were published by: Investorplace.com which released: “Costco Is Still Among the Best Retail Stocks to Buy” on June 04, 2018, also Seekingalpha.com with their article: “Costco lifts wages” published on June 01, 2018, Fool.com published: “Costco Continues to Deliver Impressive Sales Growth” on June 12, 2018. More interesting news about Costco Wholesale Corporation (NASDAQ:COST) were released by: Seekingalpha.com and their article: “I Can’t Get Behind Costco” published on June 01, 2018 as well as Seekingalpha.com‘s news article titled: “Costco Investors Can’t Ignore The Valuation” with publication date: May 31, 2018.

Among 33 analysts covering Costco Wholesale (NASDAQ:COST), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Costco Wholesale had 133 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Friday, October 6 with “Hold”. The rating was maintained by Argus Research with “Buy” on Thursday, December 10. The company was upgraded on Tuesday, June 20 by Northcoast. The firm has “Hold” rating given on Friday, May 26 by Jefferies. The company was initiated on Friday, February 10 by Susquehanna. On Wednesday, July 5 the stock rating was maintained by Wells Fargo with “Hold”. The rating was maintained by Oppenheimer on Thursday, August 24 with “Buy”. The rating was maintained by RBC Capital Markets on Friday, November 10 with “Buy”. The firm has “Buy” rating by Citigroup given on Friday, June 1. The rating was initiated by Bernstein on Monday, February 6 with “Mkt Perform”.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Fool.com which released: “Is AbbVie Inc. (ABBV) a Buy?” on May 30, 2018, also Seekingalpha.com with their article: “More Thoughts On AbbVie’s Rova-T Implosion” published on June 06, 2018, Streetinsider.com published: “AbbVie (ABBV) Highlights Data from Phase 3 Relapsed/Refractory Chronic Lymphocytic Leukemia MURANO Trial of …” on June 15, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Fool.com and their article: “Better Buy: AbbVie Inc. vs. GlaxoSmithKline plc” published on June 15, 2018 as well as Globenewswire.com‘s news article titled: “Analysis: Positioning to Benefit within Canopy Growth, Aurora Cannabis, CannTrust, AbbVie, Cronos Group, and Scotts …” with publication date: June 15, 2018.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 earnings per share, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $2.98 billion for 12.64 P/E if the $1.97 EPS becomes a reality. After $1.87 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

Among 24 analysts covering Abbvie Inc (NYSE:ABBV), 9 have Buy rating, 3 Sell and 12 Hold. Therefore 38% are positive. Abbvie Inc had 96 analyst reports since July 21, 2015 according to SRatingsIntel. PiperJaffray downgraded AbbVie Inc. (NYSE:ABBV) on Friday, June 1 to “Neutral” rating. The stock of AbbVie Inc. (NYSE:ABBV) earned “Equal-Weight” rating by Barclays Capital on Tuesday, December 1. The rating was maintained by Bernstein with “Hold” on Thursday, March 22. The firm has “Hold” rating by Deutsche Bank given on Tuesday, March 15. The firm earned “Equal-Weight” rating on Wednesday, June 8 by Morgan Stanley. The stock of AbbVie Inc. (NYSE:ABBV) earned “Hold” rating by Piper Jaffray on Friday, June 1. SunTrust maintained AbbVie Inc. (NYSE:ABBV) rating on Monday, October 16. SunTrust has “Buy” rating and $95.0 target. The firm has “Buy” rating given on Friday, September 15 by Piper Jaffray. The rating was upgraded by Deutsche Bank to “Hold” on Thursday, September 28. As per Tuesday, January 30, the company rating was downgraded by BMO Capital Markets.

Since December 18, 2017, it had 0 insider buys, and 9 sales for $25.06 million activity. RICHMOND TIMOTHY J. sold $2.15 million worth of stock. Shares for $2.95 million were sold by Schumacher Laura J on Wednesday, February 28. On Wednesday, February 28 GONZALEZ RICHARD A sold $976,084 worth of AbbVie Inc. (NYSE:ABBV) or 8,280 shares. ALBAN CARLOS sold $9.57M worth of stock. Michael Robert A. sold $512,853 worth of stock or 4,294 shares. 70,928 shares were sold by CHASE WILLIAM J, worth $8.31 million on Wednesday, February 28.

Costco Wholesale Corporation (NASDAQ:COST) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *